Delivery Order SPE2DB20D7059-SPE2DB24FQFT7

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone propionate 50 mcg spray in 16 gram containers. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $1,480.18 with a completion date of May 9, 2024. The contract is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 single-award Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The order, valued at $1,095.00, is for the delivery of fluticasone propionate 50 mcg nasal spray with a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...
This federal contract award to AmerisourceBergen Drug Corp, Corporate Office Division, provides for the delivery of 16-gram fluticasone propionate nasal spray. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,163.40 and a completion date of September 27, 2024. This appears to be a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,110,625 units of fluticasone propionate 50 mcg nasal spray. The $1,128.24 order has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,142.40 firm fixed-price delivery order is for the supply of fluticasone propionate 50 mcg spray, 16 gm. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,086.00 firm fixed-price delivery order is for the supply of Fluticasone Propionate 50 mcg Nasal Spray, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including...
This federal contract award is for the delivery of fluticasone propionate nasal spray (50 mcg, 16 gm) to the Defense Logistics Agency (DLA). The $1,380.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of fluticasone propionate nasal spray (50 mcg, 16 gm) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $1,822.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on April 29, 2024. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is set for April 30, 2024. The contract does not have...
This federal contract award is for the delivery of fluticasone propionate 50 mcg spray in 16 gram units for the Defense Logistics Agency (DLA). The $1,959.08 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and a completion date of December 13, 2024. It is an open competition Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Fluticasone Prop 50 MCG Spray 16GM pharmaceutical products to the Defense Logistics Agency (DLA). The delivery order has a firm fixed price of $1,394.40 and a completion date of February 29, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQFT7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone propionate nasal spray (50 mcg, 16 gm) to the Defense Logistics Agency (DLA). The $1,394.40 fixed-price delivery order has a completion date of May 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense globally. This specific order falls under that larger contract vehicle, which enables the DLA to efficiently procure essential medical commodities for military treatment programs and facilities. The contract does not have a set-aside designation.

Generated 8/20/24, 9:19 AM